AC Immune SA Files 6-K Report
Ticker: ACIU · Form: 6-K · Filed: Apr 30, 2026 · CIK: 0001651625
| Field | Detail |
|---|---|
| Company | Ac Immune SA (ACIU) |
| Form Type | 6-K |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-issuer, routine-report
TL;DR
AC Immune SA filed a 6-K on 4/30/26, standard foreign issuer report.
AI Summary
AC Immune SA filed a Form 6-K on April 30, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself and an exhibit (EX-99.1). The company's mailing and business addresses are both listed as EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, V8, 00000.
Why It Matters
This filing indicates routine reporting by AC Immune SA as a foreign issuer, providing updates to the SEC and investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign issuer and does not contain specific financial or operational news that would indicate a change in risk.
Key Players & Entities
- AC Immune SA (company) — Filer
- EPFL INNOVATION PARK, BUILDING B (location) — Mailing and Business Address
- 1015 LAUSANNE (location) — Mailing and Business Address
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
When was this filing accepted by the SEC?
The filing was accepted on April 30, 2026, at 07:05:04.
What are the listed addresses for AC Immune SA?
The mailing and business addresses are both EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, V8, 00000.
What is the CIK number for AC Immune SA?
The CIK number for AC Immune SA is 0001651625.
What are the included document types in this filing?
The filing includes FORM 6-K and EXHIBIT 99.1.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 30, 2026 regarding AC Immune SA (ACIU).